Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GB Sciences Inc GBLX

Healthcare
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more

Recent & Breaking News (GREY:GBLX)

Legal Cannabis Market Expected to Grow Because of Continued Adoption

PR Newswire January 25, 2018

Cannabis Sales Projected to Increase as California Paves the way for Recreational use

PR Newswire January 19, 2018

GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains

PR Newswire January 8, 2018

Cannabis Industry to Grow With Expanding Legal Sales

PR Newswire January 5, 2018

Data Shows Positive Signs for the Legal Cannabis Industry

PR Newswire December 29, 2017

GB Sciences' Chief Science Officer, Dr. Andrea Small-Howard, Has Been Invited to Join the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology

PR Newswire December 26, 2017

Green Giants of the Future - The Biggest Winners Of Canada's Cannabis Boom

PR Newswire December 21, 2017

Legal Cannabis Market Shows Strength in Sales

PR Newswire December 19, 2017

Medical Cannabis Sales Increase as Legalization Spreads in the USA

PR Newswire December 14, 2017

GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits

PR Newswire December 13, 2017

GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation

PR Newswire December 5, 2017

Profits From Legal Cannabis Sales Projected to Rise

PR Newswire November 29, 2017

Legal Cannabis Market Continues to Mature

PR Newswire November 21, 2017

GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light

PR Newswire November 15, 2017

GB Sciences is Happy

PR Newswire November 13, 2017

GB Sciences Inducts Scientific Advisory Board: Dr. Andrea Small-Howard of GB Sciences, Dr. Helen Turner of Chaminade University, Dr. Norbert Kaminsky of Michigan State University, and Dr. Carlos Ríos-Bedoya of McLaren Health

GlobeNewswire November 1, 2017

GB SCIENCES, INC. PARTNERS WITH CURA CANNABIS SOLUTIONS AND ENTERS THE LUCRATIVE CANNABIS OIL MARKET IN NEVADA

GlobeNewswire October 30, 2017

The Relationship Between Legal Cannabis and the Plant Factory Grows Lights Market

PR Newswire October 26, 2017

GB Sciences Receives The Prestigious 'Spirit Of The Law' Award

PR Newswire October 26, 2017

GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain

GlobeNewswire October 23, 2017